After the identification of numerous proteins to be deregulated in a diseased tissue using iTRAQ what should be the criteria to select a few proteins for their validation using Western blotting.

  • Whether the proteins should be well known for their roles in that particular disease or these shouldn't have been reported before (novel) in this disease. 
  • This is a common practice that the proteins overexpressed in case of diseased animal/group are taken into consideration, what may be the importance of down-regulated proteins? 
  • Monoclonal or polyclonal?
  • What may be the importance of the uncharacterized proteins in such a list..
  • More Debasis Sahu's questions See All
    Similar questions and discussions